Structure

Physi-Chem Properties

Molecular Weight:  602.36
Volume:  657.955
LogP:  7.77
LogD:  5.13
LogS:  -3.735
# Rotatable Bonds:  7
TPSA:  108.74
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.142
Synthetic Accessibility Score:  6.352
Fsp3:  0.579
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.15
MDCK Permeability:  1.6168640286196023e-05
Pgp-inhibitor:  0.065
Pgp-substrate:  0.017
Human Intestinal Absorption (HIA):  0.341
20% Bioavailability (F20%):  0.976
30% Bioavailability (F30%):  0.731

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.028
Plasma Protein Binding (PPB):  99.3217544555664%
Volume Distribution (VD):  2.257
Pgp-substrate:  1.2497550249099731%

ADMET: Metabolism

CYP1A2-inhibitor:  0.01
CYP1A2-substrate:  0.509
CYP2C19-inhibitor:  0.698
CYP2C19-substrate:  0.776
CYP2C9-inhibitor:  0.774
CYP2C9-substrate:  0.98
CYP2D6-inhibitor:  0.557
CYP2D6-substrate:  0.138
CYP3A4-inhibitor:  0.844
CYP3A4-substrate:  0.879

ADMET: Excretion

Clearance (CL):  18.623
Half-life (T1/2):  0.025

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  0.134
Drug-inuced Liver Injury (DILI):  0.91
AMES Toxicity:  0.016
Rat Oral Acute Toxicity:  0.952
Maximum Recommended Daily Dose:  0.203
Skin Sensitization:  0.004
Carcinogencity:  0.215
Eye Corrosion:  0.006
Eye Irritation:  0.247
Respiratory Toxicity:  0.941

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473527

Natural Product ID:  NPC473527
Common Name*:   Guttiferone H
IUPAC Name:   n.a.
Synonyms:   Guttiferone H
Standard InCHIKey:  IIOQLCJBRQEPIR-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C38H50O6/c1-21(2)11-13-26-27-15-14-25(23(5)6)35(7,8)20-37(27)32(42)30(31(41)24-12-16-28(39)29(40)19-24)33(43)38(34(37)44,36(26,9)10)18-17-22(3)4/h11-12,16-17,19,25-27,39-40,42H,5,13-15,18,20H2,1-4,6-10H3
SMILES:  CC(=CCC12C(=O)C(=C(C3(C1=O)CC(C)(C)C(CCC3C(C2(C)C)CC=C(C)C)C(=C)C)O)C(=O)c1ccc(c(c1)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL444720
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001549] Monoterpenoids
          • [CHEMONTID:0000051] Aromatic monoterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21424 Garcinia xanthochymus Species Clusiaceae Eukaryota n.a. xylem n.a. PMID[14600386]
NPO21424 Garcinia xanthochymus Species Clusiaceae Eukaryota fruits n.a. n.a. PMID[15787435]
NPO21424 Garcinia xanthochymus Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21424 Garcinia xanthochymus Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21424 Garcinia xanthochymus Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT660 Cell Line SW480 Homo sapiens IC50 = 12400.0 nM PMID[544682]
NPT660 Cell Line SW480 Homo sapiens Activity = 11.8 % PMID[544682]
NPT660 Cell Line SW480 Homo sapiens Activity = 15.6 % PMID[544682]
NPT660 Cell Line SW480 Homo sapiens Activity = 19.8 % PMID[544682]
NPT660 Cell Line SW480 Homo sapiens Activity = 48.0 % PMID[544682]
NPT660 Cell Line SW480 Homo sapiens Activity = 80.0 % PMID[544682]
NPT1 Others Radical scavenging activity IC50 = 64000.0 nM PMID[544682]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473527 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.985 High Similarity NPC245760
0.985 High Similarity NPC165191
0.985 High Similarity NPC5014
0.985 High Similarity NPC42384
0.985 High Similarity NPC28592
0.985 High Similarity NPC149773
0.985 High Similarity NPC114333
0.985 High Similarity NPC289358
0.985 High Similarity NPC46242
0.985 High Similarity NPC297797
0.985 High Similarity NPC91887
0.985 High Similarity NPC23667
0.985 High Similarity NPC469857
0.985 High Similarity NPC51531
0.985 High Similarity NPC477849
0.985 High Similarity NPC473479
0.985 High Similarity NPC157284
0.985 High Similarity NPC473779
0.985 High Similarity NPC50615
0.9776 High Similarity NPC294330
0.9699 High Similarity NPC7464
0.9562 High Similarity NPC471971
0.9562 High Similarity NPC30846
0.9562 High Similarity NPC469855
0.9562 High Similarity NPC471972
0.9424 High Similarity NPC145301
0.9424 High Similarity NPC294679
0.9424 High Similarity NPC469856
0.9424 High Similarity NPC144247
0.9424 High Similarity NPC469375
0.9424 High Similarity NPC8493
0.9424 High Similarity NPC469854
0.9412 High Similarity NPC471974
0.9412 High Similarity NPC469681
0.9412 High Similarity NPC469680
0.9291 High Similarity NPC471970
0.9173 High Similarity NPC25736
0.9161 High Similarity NPC264229
0.9161 High Similarity NPC132810
0.9161 High Similarity NPC46549
0.9097 High Similarity NPC237441
0.9044 High Similarity NPC474715
0.9021 High Similarity NPC273798
0.8904 High Similarity NPC48949
0.8851 High Similarity NPC305710
0.8768 High Similarity NPC4170
0.8768 High Similarity NPC138472
0.8652 High Similarity NPC118366
0.8652 High Similarity NPC277559
0.8633 High Similarity NPC111845
0.8592 High Similarity NPC230811
0.8551 High Similarity NPC117609
0.854 High Similarity NPC234175
0.8521 High Similarity NPC49911
0.8511 High Similarity NPC43353
0.8511 High Similarity NPC153088
0.85 High Similarity NPC294226
0.8487 Intermediate Similarity NPC471968
0.8472 Intermediate Similarity NPC470035
0.8435 Intermediate Similarity NPC470038
0.8425 Intermediate Similarity NPC199936
0.838 Intermediate Similarity NPC258502
0.8356 Intermediate Similarity NPC184935
0.8345 Intermediate Similarity NPC471853
0.8345 Intermediate Similarity NPC476534
0.8333 Intermediate Similarity NPC416
0.8333 Intermediate Similarity NPC72667
0.8333 Intermediate Similarity NPC61398
0.8322 Intermediate Similarity NPC10842
0.8311 Intermediate Similarity NPC258856
0.8264 Intermediate Similarity NPC471152
0.8261 Intermediate Similarity NPC254492
0.8261 Intermediate Similarity NPC15837
0.8252 Intermediate Similarity NPC72918
0.8231 Intermediate Similarity NPC291078
0.8231 Intermediate Similarity NPC176030
0.8231 Intermediate Similarity NPC248068
0.8231 Intermediate Similarity NPC192597
0.8231 Intermediate Similarity NPC169214
0.8231 Intermediate Similarity NPC229218
0.8231 Intermediate Similarity NPC141817
0.8214 Intermediate Similarity NPC171460
0.8201 Intermediate Similarity NPC78364
0.8201 Intermediate Similarity NPC84672
0.8201 Intermediate Similarity NPC324209
0.8201 Intermediate Similarity NPC69424
0.8201 Intermediate Similarity NPC176130
0.82 Intermediate Similarity NPC52692
0.8195 Intermediate Similarity NPC150919
0.8194 Intermediate Similarity NPC474311
0.8188 Intermediate Similarity NPC75295
0.8158 Intermediate Similarity NPC470037
0.8156 Intermediate Similarity NPC108129
0.8151 Intermediate Similarity NPC472903
0.8143 Intermediate Similarity NPC96024
0.8138 Intermediate Similarity NPC290030
0.8138 Intermediate Similarity NPC147418
0.8138 Intermediate Similarity NPC264022
0.8138 Intermediate Similarity NPC475957
0.8125 Intermediate Similarity NPC478060
0.8125 Intermediate Similarity NPC471975
0.8125 Intermediate Similarity NPC470374
0.8125 Intermediate Similarity NPC478059
0.8125 Intermediate Similarity NPC470377
0.8116 Intermediate Similarity NPC199273
0.8116 Intermediate Similarity NPC15127
0.8112 Intermediate Similarity NPC477139
0.8112 Intermediate Similarity NPC53896
0.8102 Intermediate Similarity NPC91478
0.8095 Intermediate Similarity NPC203063
0.8088 Intermediate Similarity NPC236520
0.8088 Intermediate Similarity NPC294361
0.8085 Intermediate Similarity NPC276238
0.8085 Intermediate Similarity NPC117899
0.8082 Intermediate Similarity NPC87723
0.8071 Intermediate Similarity NPC471530
0.8069 Intermediate Similarity NPC65005
0.8069 Intermediate Similarity NPC194764
0.8069 Intermediate Similarity NPC193358
0.8069 Intermediate Similarity NPC264112
0.8056 Intermediate Similarity NPC202225
0.8056 Intermediate Similarity NPC50924
0.8054 Intermediate Similarity NPC224884
0.8054 Intermediate Similarity NPC209085
0.8041 Intermediate Similarity NPC472904
0.8029 Intermediate Similarity NPC120545
0.8014 Intermediate Similarity NPC53001
0.8014 Intermediate Similarity NPC193203
0.8013 Intermediate Similarity NPC143685
0.8 Intermediate Similarity NPC80035
0.8 Intermediate Similarity NPC3224
0.8 Intermediate Similarity NPC71610
0.8 Intermediate Similarity NPC196941
0.8 Intermediate Similarity NPC309169
0.7987 Intermediate Similarity NPC144283
0.7987 Intermediate Similarity NPC477873
0.7987 Intermediate Similarity NPC469447
0.7987 Intermediate Similarity NPC35
0.7987 Intermediate Similarity NPC193555
0.7986 Intermediate Similarity NPC115458
0.7985 Intermediate Similarity NPC277394
0.7985 Intermediate Similarity NPC61062
0.7985 Intermediate Similarity NPC299252
0.7972 Intermediate Similarity NPC18798
0.7972 Intermediate Similarity NPC17083
0.7972 Intermediate Similarity NPC471851
0.7972 Intermediate Similarity NPC244699
0.7972 Intermediate Similarity NPC291001
0.7971 Intermediate Similarity NPC282577
0.7971 Intermediate Similarity NPC86900
0.7959 Intermediate Similarity NPC206207
0.7959 Intermediate Similarity NPC4214
0.7959 Intermediate Similarity NPC13715
0.7958 Intermediate Similarity NPC303910
0.7947 Intermediate Similarity NPC73416
0.7947 Intermediate Similarity NPC160777
0.7945 Intermediate Similarity NPC472308
0.7943 Intermediate Similarity NPC107672
0.7933 Intermediate Similarity NPC238629
0.7933 Intermediate Similarity NPC239608
0.7933 Intermediate Similarity NPC46161
0.7931 Intermediate Similarity NPC293454
0.7931 Intermediate Similarity NPC475088
0.7927 Intermediate Similarity NPC471969
0.7919 Intermediate Similarity NPC472410
0.7919 Intermediate Similarity NPC84273
0.7917 Intermediate Similarity NPC135801
0.7917 Intermediate Similarity NPC175738
0.791 Intermediate Similarity NPC322197
0.7899 Intermediate Similarity NPC154696
0.7895 Intermediate Similarity NPC234637
0.7895 Intermediate Similarity NPC130591
0.7895 Intermediate Similarity NPC476535
0.7891 Intermediate Similarity NPC36868
0.7887 Intermediate Similarity NPC3009
0.7887 Intermediate Similarity NPC229894
0.7887 Intermediate Similarity NPC48248
0.7881 Intermediate Similarity NPC79627
0.7881 Intermediate Similarity NPC53520
0.7877 Intermediate Similarity NPC249272
0.7877 Intermediate Similarity NPC477596
0.7877 Intermediate Similarity NPC283088
0.7872 Intermediate Similarity NPC306765
0.7871 Intermediate Similarity NPC124842
0.7867 Intermediate Similarity NPC11314
0.7862 Intermediate Similarity NPC78307
0.7862 Intermediate Similarity NPC327410
0.7857 Intermediate Similarity NPC142654
0.7852 Intermediate Similarity NPC181560
0.7852 Intermediate Similarity NPC169452
0.7847 Intermediate Similarity NPC469526
0.7847 Intermediate Similarity NPC243305
0.7847 Intermediate Similarity NPC34070
0.7843 Intermediate Similarity NPC476821
0.7842 Intermediate Similarity NPC139171
0.7842 Intermediate Similarity NPC68167
0.7838 Intermediate Similarity NPC141368
0.7838 Intermediate Similarity NPC473622
0.7834 Intermediate Similarity NPC472807
0.7832 Intermediate Similarity NPC34414

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473527 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8163 Intermediate Similarity NPD8166 Discontinued
0.7917 Intermediate Similarity NPD943 Approved
0.7883 Intermediate Similarity NPD2932 Approved
0.7754 Intermediate Similarity NPD3019 Approved
0.7703 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD1470 Approved
0.7597 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD1201 Approved
0.7468 Intermediate Similarity NPD3300 Phase 2
0.7464 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7463 Intermediate Similarity NPD3022 Approved
0.7463 Intermediate Similarity NPD3021 Approved
0.7429 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD3023 Approved
0.7324 Intermediate Similarity NPD3026 Approved
0.7305 Intermediate Similarity NPD3024 Approved
0.7305 Intermediate Similarity NPD3025 Approved
0.7222 Intermediate Similarity NPD9269 Phase 2
0.7222 Intermediate Similarity NPD3972 Approved
0.7222 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD9494 Approved
0.7202 Intermediate Similarity NPD7473 Discontinued
0.7197 Intermediate Similarity NPD7390 Discontinued
0.719 Intermediate Similarity NPD5405 Approved
0.719 Intermediate Similarity NPD5406 Approved
0.719 Intermediate Similarity NPD5408 Approved
0.719 Intermediate Similarity NPD5404 Approved
0.7172 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD6663 Approved
0.7124 Intermediate Similarity NPD2799 Discontinued
0.7117 Intermediate Similarity NPD2801 Approved
0.7095 Intermediate Similarity NPD5736 Approved
0.7089 Intermediate Similarity NPD1511 Approved
0.7081 Intermediate Similarity NPD7458 Discontinued
0.7055 Intermediate Similarity NPD1934 Approved
0.7039 Intermediate Similarity NPD230 Phase 1
0.7032 Intermediate Similarity NPD2344 Approved
0.703 Intermediate Similarity NPD3882 Suspended
0.7024 Intermediate Similarity NPD6232 Discontinued
0.7007 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD4628 Phase 3
0.7006 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1512 Approved
0.6975 Remote Similarity NPD3226 Approved
0.697 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6968 Remote Similarity NPD2935 Discontinued
0.6959 Remote Similarity NPD1164 Approved
0.6954 Remote Similarity NPD3764 Approved
0.695 Remote Similarity NPD5951 Approved
0.6944 Remote Similarity NPD9268 Approved
0.6933 Remote Similarity NPD7028 Phase 2
0.6932 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6923 Remote Similarity NPD2346 Discontinued
0.6923 Remote Similarity NPD1471 Phase 3
0.6918 Remote Similarity NPD3092 Approved
0.6913 Remote Similarity NPD2798 Approved
0.6909 Remote Similarity NPD7819 Suspended
0.6899 Remote Similarity NPD7003 Approved
0.6893 Remote Similarity NPD8434 Phase 2
0.6875 Remote Similarity NPD3091 Approved
0.6855 Remote Similarity NPD2309 Approved
0.6855 Remote Similarity NPD6190 Approved
0.6846 Remote Similarity NPD3094 Phase 2
0.6835 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6824 Remote Similarity NPD1755 Approved
0.6818 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6812 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6798 Remote Similarity NPD8150 Discontinued
0.6797 Remote Similarity NPD8032 Phase 2
0.6795 Remote Similarity NPD1510 Phase 2
0.6791 Remote Similarity NPD3020 Approved
0.679 Remote Similarity NPD6273 Approved
0.6781 Remote Similarity NPD4059 Approved
0.6781 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6781 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6779 Remote Similarity NPD1876 Approved
0.6774 Remote Similarity NPD6651 Approved
0.6774 Remote Similarity NPD1607 Approved
0.6763 Remote Similarity NPD3818 Discontinued
0.6757 Remote Similarity NPD4878 Approved
0.6753 Remote Similarity NPD3620 Phase 2
0.6753 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6753 Remote Similarity NPD1240 Approved
0.6752 Remote Similarity NPD6099 Approved
0.6752 Remote Similarity NPD6100 Approved
0.675 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6744 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6744 Remote Similarity NPD6166 Phase 2
0.6744 Remote Similarity NPD6167 Clinical (unspecified phase)
0.673 Remote Similarity NPD2800 Approved
0.6728 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6727 Remote Similarity NPD4380 Phase 2
0.6726 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6706 Remote Similarity NPD5494 Approved
0.669 Remote Similarity NPD5536 Phase 2
0.669 Remote Similarity NPD7610 Discontinued
0.6689 Remote Similarity NPD258 Approved
0.6689 Remote Similarity NPD257 Approved
0.6687 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7075 Discontinued
0.6686 Remote Similarity NPD7074 Phase 3
0.6667 Remote Similarity NPD8127 Discontinued
0.6667 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3095 Discontinued
0.6667 Remote Similarity NPD1283 Approved
0.6667 Remote Similarity NPD3455 Phase 2
0.6667 Remote Similarity NPD970 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6644 Remote Similarity NPD9545 Approved
0.6629 Remote Similarity NPD7054 Approved
0.6627 Remote Similarity NPD6599 Discontinued
0.6626 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6623 Remote Similarity NPD3268 Approved
0.6623 Remote Similarity NPD2313 Discontinued
0.662 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6617 Remote Similarity NPD1432 Clinical (unspecified phase)
0.661 Remote Similarity NPD7685 Pre-registration
0.661 Remote Similarity NPD5027 Approved
0.661 Remote Similarity NPD5031 Approved
0.661 Remote Similarity NPD5029 Approved
0.6607 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6607 Remote Similarity NPD1465 Phase 2
0.6605 Remote Similarity NPD7236 Approved
0.6603 Remote Similarity NPD447 Suspended
0.6599 Remote Similarity NPD1651 Approved
0.6591 Remote Similarity NPD7472 Approved
0.6587 Remote Similarity NPD7411 Suspended
0.6587 Remote Similarity NPD6873 Phase 2
0.6584 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6584 Remote Similarity NPD3750 Approved
0.6584 Remote Similarity NPD4110 Phase 3
0.6573 Remote Similarity NPD4954 Approved
0.6573 Remote Similarity NPD36 Approved
0.6573 Remote Similarity NPD7635 Approved
0.6573 Remote Similarity NPD5032 Approved
0.6573 Remote Similarity NPD4955 Approved
0.6573 Remote Similarity NPD5026 Approved
0.6573 Remote Similarity NPD5028 Approved
0.6573 Remote Similarity NPD5034 Approved
0.6568 Remote Similarity NPD5977 Approved
0.6568 Remote Similarity NPD3817 Phase 2
0.6568 Remote Similarity NPD5978 Approved
0.6567 Remote Similarity NPD2859 Approved
0.6567 Remote Similarity NPD2860 Approved
0.6562 Remote Similarity NPD1549 Phase 2
0.6558 Remote Similarity NPD7095 Approved
0.6558 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6554 Remote Similarity NPD1751 Approved
0.6554 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6552 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6545 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6538 Remote Similarity NPD826 Approved
0.6538 Remote Similarity NPD825 Approved
0.6536 Remote Similarity NPD5035 Approved
0.6534 Remote Similarity NPD5844 Phase 1
0.6525 Remote Similarity NPD74 Approved
0.6525 Remote Similarity NPD9266 Approved
0.6524 Remote Similarity NPD2532 Approved
0.6524 Remote Similarity NPD2534 Approved
0.6524 Remote Similarity NPD2533 Approved
0.6522 Remote Similarity NPD1930 Approved
0.6522 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6522 Remote Similarity NPD1929 Approved
0.6517 Remote Similarity NPD7251 Discontinued
0.6517 Remote Similarity NPD5030 Phase 2
0.6507 Remote Similarity NPD9493 Approved
0.65 Remote Similarity NPD1552 Clinical (unspecified phase)
0.65 Remote Similarity NPD7266 Discontinued
0.65 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6493 Remote Similarity NPD2934 Approved
0.6493 Remote Similarity NPD2933 Approved
0.6489 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6483 Remote Similarity NPD2629 Approved
0.648 Remote Similarity NPD7808 Phase 3
0.6474 Remote Similarity NPD6959 Discontinued
0.6467 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6467 Remote Similarity NPD1281 Approved
0.6461 Remote Similarity NPD6797 Phase 2
0.6454 Remote Similarity NPD9263 Approved
0.6454 Remote Similarity NPD9264 Approved
0.6454 Remote Similarity NPD9267 Approved
0.6453 Remote Similarity NPD6234 Discontinued
0.6448 Remote Similarity NPD6836 Approved
0.6444 Remote Similarity NPD8312 Approved
0.6444 Remote Similarity NPD8313 Approved
0.6441 Remote Similarity NPD1221 Approved
0.6438 Remote Similarity NPD2796 Approved
0.6433 Remote Similarity NPD7768 Phase 2
0.6429 Remote Similarity NPD9569 Approved
0.6429 Remote Similarity NPD5038 Approved
0.6429 Remote Similarity NPD5037 Approved
0.6424 Remote Similarity NPD1608 Approved
0.6423 Remote Similarity NPD2066 Phase 3
0.6419 Remote Similarity NPD7009 Phase 2
0.6414 Remote Similarity NPD5283 Phase 1
0.6412 Remote Similarity NPD5760 Phase 2
0.6412 Remote Similarity NPD5761 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data